[HTML][HTML] Anticoagulation in cardiovascular diseases: evolving role, unmet needs, and grey areas
Thrombosis is a key pathophysiological mechanism for many serious cardiovascular
diseases, including deep vein thrombosis (DVT), pulmonary embolism (PE), acute coronary …
diseases, including deep vein thrombosis (DVT), pulmonary embolism (PE), acute coronary …
[PDF][PDF] Anticoagulation in cardiovascular diseases: evolving role, unmet needs, and grey areas
A Tuttolomondo, P Pignatelli, R Pola - 2023 - scienceopen.com
Thrombosis is a key pathophysiological mechanism for many serious cardiovascular
diseases, including deep vein thrombosis (DVT), pulmonary embolism (PE), acute coronary …
diseases, including deep vein thrombosis (DVT), pulmonary embolism (PE), acute coronary …
[PDF][PDF] Anticoagulation in cardiovascular diseases: evolving role, unmet needs, and grey areas
A Tuttolomondo, P Pignatelli, R Pola - 2023 - iris.unipa.it
Thrombosis is a key pathophysiological mechanism for many serious cardiovascular
diseases, including deep vein thrombosis (DVT), pulmonary embolism (PE), acute coronary …
diseases, including deep vein thrombosis (DVT), pulmonary embolism (PE), acute coronary …
Anticoagulation in cardiovascular diseases: evolving role, unmet needs, and grey areas
A Tuttolomondo, P Pignatelli, R Pola - Frontiers in Cardiovascular …, 2023 - europepmc.org
Thrombi consist of aggregated platelets, fibrin, and trapped cells, with the distribution of
these components differing substantially between arterial and venous thrombi (1). The main …
these components differing substantially between arterial and venous thrombi (1). The main …
[引用][C] Anticoagulation in cardiovascular diseases: evolving role, unmet needs, and grey areas
A Tuttolomondo, P Pignatelli… - Frontiers in …, 2023 - pubmed.ncbi.nlm.nih.gov
Editorial: Anticoagulation in cardiovascular diseases: evolving role, unmet needs, and grey
areas Editorial: Anticoagulation in cardiovascular diseases: evolving role, unmet needs, and …
areas Editorial: Anticoagulation in cardiovascular diseases: evolving role, unmet needs, and …
[HTML][HTML] Anticoagulation in cardiovascular diseases: evolving role, unmet needs, and grey areas
A Tuttolomondo, P Pignatelli, R Pola - Frontiers in Cardiovascular …, 2023 - ncbi.nlm.nih.gov
Thrombosis is a key pathophysiological mechanism for many serious cardiovascular
diseases, including deep vein thrombosis (DVT), pulmonary embolism (PE), acute coronary …
diseases, including deep vein thrombosis (DVT), pulmonary embolism (PE), acute coronary …
[引用][C] Anticoagulation in cardiovascular diseases: evolving role, unmet needs, and grey areas
A Tuttolomondo, P Pignatelli, R Pola - FRONTIERS IN …, 2023 - iris.unipa.it
Editorial: Anticoagulation in cardiovascular diseases: evolving role, unmet needs, and grey
areas IRIS IRIS Home Sfoglia Macrotipologie & tipologie Autore Titolo Data di pubblicazione …
areas IRIS IRIS Home Sfoglia Macrotipologie & tipologie Autore Titolo Data di pubblicazione …
[引用][C] Anticoagulation in cardiovascular diseases: evolving role, unmet needs, and grey areas.
A Tuttolomondo, P Pignatelli, R Pola - Frontiers in Cardiovascular …, 2023 - europepmc.org
Editorial: Anticoagulation in cardiovascular diseases: evolving role, unmet needs, and grey
areas. - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu …
areas. - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu …